… immune response.” What does your current role, Chief Innovation Officer, entail? “My responsibility is the … to (our CEO) Daniel that he wants to invest so much in innovation. About one third of the company is dedicated to …
There are currently around 160 people working at ProQR, but that wasn’t always the case. When Hee Lam Chan joined in 2013, she was only employee number six. As a result, she has seen the company grow and develop.
Bart Klein was at the forefront of ProQR's Axiomer® RNA editing technology development. This platform technology makes it possible to use the cells own machinery to reverse mutations that cause a genetic disease. Read the interview.
… market and will hopefully contribute to bringing future innovations into the industry. Leiden student learning about … ProQR provided the students with tours of our innovative laboratories in Leiden, including the R&D, CMC and …
… of our collaboration with Lilly. Lilly is a leader in innovative RNA science, making them a great partner for our … developing the medicines of tomorrow takes time, sustained innovation and most importantly, collaboration. Andrew C. …
